Park Ha Biological Technology Co., Ltd. Ordinary Shares cash flow to debt ratio of 47.65% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Park Ha Biological Technology Co., Ltd. Ordinary Shares's free cash flow has decreased 100.34% from $874.90K last year to $-2.97K, signaling decreasing performance

Park Ha Biological Technology Co., Ltd. Ordinary Shares's debt to equity ratio is 0.03, which means that the company's assets are healthy financed, signaling financial stability.

Park Ha Biological Technology Co., Ltd. Ordinary Shares's debt has decreased relative to shareholder equity from 0.05 last year to 0.03 today, signaling strengthened financials

Park Ha Biological Technology Co., Ltd. Ordinary Shares has a net cash position, so leverage is healthy.

Park Ha Biological Technology Co., Ltd. Ordinary Shares earns at least as much interest as it pays. Interest obligations are fully covered.

Park Ha Biological Technology Co., Ltd. Ordinary Shares's profit margin has decreased (1.17K%) in the last year from 20.09% to -214.17%, signaling decreasing performance

Park Ha Biological Technology Co., Ltd. Ordinary Shares's short-term assets of $5.50M exceed its short-term liabilities of $1.88M

Park Ha Biological Technology Co., Ltd. Ordinary Shares's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Park Ha Biological Technology Co., Ltd. Ordinary Shares's return on equity of -174.17%, is lower than 15.00%, indicating bad performance

Park Ha Biological Technology Co., Ltd. Ordinary Shares's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Park Ha Biological Technology Co., Ltd. Ordinary Shares has insufficient public price history to evaluate earnings stability.

Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative free cash flow, indicating the company is burning cash rather than generating it

Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative free cash flow, indicating cash burn

Park Ha Biological Technology Co., Ltd. Ordinary Shares's yearly earnings has decreased 5.19K% since last year from $478.56K to $-24.36M, signaling decreasing performance

Park Ha Biological Technology Co., Ltd. Ordinary Shares's yearly revenue has increased 6.00% since last year from $2.38M to $2.52M, signaling increasing performance

ROIC -145.22% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Park Ha Biological Technology Co., Ltd. Ordinary Shares's 3-year revenue CAGR of 9.57% is positive, indicating growing revenue over the past 3 years

Park Ha Biological Technology Co., Ltd. Ordinary Shares has insufficient public price history to evaluate revenue consistency.

Park Ha Biological Technology Co., Ltd. Ordinary Shares has insufficient public price history to evaluate ROE consistency.

Park Ha Biological Technology Co., Ltd. Ordinary Shares has insufficient data to evaluate this check.

Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Park Ha Biological Technology Co., Ltd. Ordinary Shares is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Park Ha Biological Technology Co., Ltd. Ordinary Shares has insufficient data to evaluate this check.

Park Ha Biological Technology Co., Ltd. Ordinary Shares has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Park Ha Biological Technology Co., Ltd. Ordinary Shares has a price-to-book ratio of 0.39x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Park Ha Biological Technology Co., Ltd. Ordinary Shares has a price-to-sales ratio of 0.56x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue